https://lumen.bio/ 2026-04-03T12:22:30.589Z monthly 1 https://lumen.bio/news 2026-04-03T12:22:30.589Z weekly 0.9 https://lumen.bio/fcoi weekly 0.8 https://lumen.bio/pipeline weekly 0.8 https://lumen.bio/po-terms weekly 0.8 https://lumen.bio/privacy-policy weekly 0.8 https://lumen.bio/about weekly 0.8 https://lumen.bio/careers weekly 0.8 https://lumen.bio/science weekly 0.8 https://lumen.bio/contact-us weekly 0.8 https://lumen.bio/expanded-access-policy weekly 0.8 https://lumen.bio/news/2026/01/13/the-future-of-biotech-is-preventive-and-global 2026-01-13T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/12/23/china-biotech-s-cambrian-explosion 2025-12-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/11/20/pentagon-backed-lumen-is-ready-to-drastically-slash-antibody-manufacturing-costs 2025-11-20T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/11/03/how-the-u-s-can-beat-china-in-biotech 2025-11-03T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/10/08/lumen-bioscience-raises-30-m-series-c-extension 2025-10-08T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/10/08/lumen-bioscience-expands-board-and-leadership-team-to-advance-clinical-pipeline-of-novel-oral-biologics 2025-10-08T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/09/16/the-smart-model-a-simplified-model-for-assessing-the-resilience-of-therapeutic-program-financial-viability 2025-09-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/06/04/revolutionizing-the-production-of-biologics-with-algae 2025-06-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/06/03/4-ideas-to-kick-start-u-s-drug-research-and-beat-china-in-biotech 2025-06-03T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/05/30/past-wilkes-prize-winners-accelerate-audacious-climate-solutions 2025-05-30T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/05/26/reviewing-real-world-safety-and-efficacy-data-on-c-difficile-therapy-rebyota 2025-05-26T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/04/03/investigational-oral-biologic-achieves-100-c-difficile-clinical-cure-in-preliminary-cohort 2025-04-03T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/04/02/lmn-201-achieves-100-initial-c-difficile-clinical-cure-in-preliminary-cohort-of-re-preve-trial 2025-04-02T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2025/02/14/preventive-antimicrobials-a-promising-solution-to-antibiotic-resistance 2025-02-14T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/11/07/preventive-biologics-may-aid-the-antibiotic-resistance-crisis 2024-11-07T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/08/06/qa-biologic-drugs-are-reinvented-to-treat-infectious-diseases 2024-08-06T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/07/08/obesity-market-review 2024-07-08T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/06/18/clinical-development-of-preventive-antimicrobials 2024-06-18T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/05/29/congratulations-to-the-winners-of-the-9th-annual-mtec-membership-meeting-awards-4 2024-05-29T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/03/15/drug-developers-navigating-biologys-century-need-a-model-we-made-one 2024-03-15T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/03/04/the-innovators-dilemma-with-lumen-biosciences-brian-finrow-j-d 2024-03-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2024/01/19/lumen-bioscience-cracks-the-code-on-spirulina-as-a-biologics-factory-for-c-diff-metabolic-disease-and-more 2024-01-19T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/12/14/reinventing-drug-invention 2023-12-14T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/11/30/lumen-bioscience-bags-5-5-million-to-develop-needle-free-vaccines 2023-11-30T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/11/29/lumen-bioscience-announces-5-5-million-funding-to-support-new-research-program-for-mucosal-vaccine-platform-technology 2023-11-29T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/11/17/reinventing-how-drugs-are-invented-making-a-case-for-simplicity-in-drug-development-and-production 2023-11-17T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/10/22/lumen-bioscience-secures-dod-funding-for-infection-treatment 2023-10-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/10/18/stat-preventive-drugs-may-be-the-best-solution-to-the-antibiotic-resistance-crisis 2023-10-18T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/10/16/lumen-bioscience-awarded-16-2-million-in-dod-funding-to-advance-lmn-201-through-late-stage-trials 2023-10-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/10/11/cows-burp-out-too-much-methane-lumen-bioscience-is-making-a-bovine-beano 2023-10-11T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/10/04/lumen-bioscience-data-show-needle-free-spirulina-produced-vaccination-protects-against-malaria 2023-10-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/10/02/belching-cattle-cause-major-damage-to-the-climate-heres-how-a-1-5-million-prize-from-the-u-of-u-could-help-change-that 2023-10-02T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/09/26/cows-burp-out-too-much-methane-this-biotech-startup-is-making-a-bovine-beano 2023-09-26T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/09/22/lumen-bioscience-wins-historic-1-5m-wilkes-center-climate-prize 2023-09-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/09/22/cow-farts-are-bad-for-earth-but-cow-burps-are-worse-new-plan-could-help-cows-belch-less 2023-09-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/09/22/2023-wilkes-center-climate-prize-winner-lumen-bioscience 2023-09-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/07/14/investigational-c-diff-antibody-takes-novel-mechanism-of-action-approach 2023-07-14T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/05/17/lumen-bioscience-receives-fast-track-designation-us-fda-lmn-201 2023-05-17T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/05/10/lumen-bioscience-awarded-8-1-million-from-u-s-department-of-defense-to-develop-fast-acting-intranasal-countermeasure-against-respiratory-viruses 2023-05-10T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/03/10/brian-finrow-ceo-of-lumen-bioscience-on-the-executive 2023-03-10T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/03/01/addressing-the-grand-challenge-of-global-access-to-vaccines 2023-03-01T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/02/21/protocol-for-the-transformation-and-engineering-of-edible-algae-arthrospira-platensis-to-generate-heterologous-protein-expressing-strains 2023-02-21T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/01/16/lumen-bio-we-face-2023-with-tremendous-optimism 2023-01-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/01/12/reporters-notebook-on-day-2-of-j-p-morgan-start-ups-soliciting-cash-and-vcs-eschewing-high-risk 2023-01-12T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/01/05/lumen-bioscience-details-2022-company-and-facilities-growth-new-funding-and-clinical-pipeline-progress 2023-01-05T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2023/01/04/lumen-bioscience-receives-broad-funding-support-for-advancement-of-antibiotic-alternative-for-preventing-travelers-diarrhea 2023-01-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/12/27/biotech-industry-leaders-share-cautious-optimism-for-2023-amid-downturn-and-layoffs-1 2022-12-27T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/12/23/lumen-bioscience-awarded-3-6-million-by-us-army-to-advance-low-cost-scalable-preventative-for-antibiotic-resistant-infections 2022-12-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/12/20/barda-funded-intranasal-antibody-cocktail-for-covid-19-shows-promise-in-a-preclinical-study 2022-12-20T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/12/07/lumens-ai-analysis-frees-production-optimization-from-doe-limits 2022-12-07T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/11/18/improving-combination-drug-trials-using-definitive-screening-designs 2022-11-18T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/10/25/on-the-horizon-needle-free-vaccines-could-offer-better-protection-and-access 2022-10-25T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/10/04/needle-free-spirulina-produced-plasmodium-falciparum-circumsporozoite-vaccination-provides-sterile-protection-against-pre-erythrocytic-malaria-in-mice 2022-10-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/10/04/algae-grown-non-needle-malaria-vaccine-in-preclinical-test 2022-10-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/10/04/lumen-bioscience-announces-publication-in-npj-vaccines-of-preclinical-data-demonstrating-needle-free-spirulina-produced-vaccination-offering-protection-against-malaria 2022-10-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/07/16/brian-finrow-co-founder-and-ceo-of-lumen-bioscience-speaks-with-bioboss-host-and-biopharma-branding-veteran-john-simboli 2022-07-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/06/25/algae-encoded-biopharmaceuticals 2022-06-25T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/05/17/lumen-bioscience-hacks-spirulina-to-generate-biologics 2022-05-17T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/04/27/barda-and-lumen-bioscience-partner-on-a-rapidly-scalable-novel-manufacturing-platform-to-develop-an-intranasal-antibody-cocktail-to-treat-covid-19-2 2022-04-27T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/04/25/when-free-markets-fail-and-maybe-you-die 2022-04-25T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/04/18/moving-closer-to-the-patient-1 2022-04-18T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/04/18/trial-set-for-gut-infection-biologic-treatment 2022-04-18T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/04/15/lumen-bioscience-announces-clinical-advancement-of-lmn-201-for-c-difficile-infection 2022-04-15T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/04/06/a-spirulina-based-biomanufacturing-platform 2022-04-06T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/03/30/kyorin-and-lumen-bioscience-reach-collaboration-research-agreement 2022-03-30T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/03/24/spirulina-based-platform-for-ultra-large-scale-production-of-therapeutic-proteins 2022-03-24T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/03/21/how-spirulina-could-help-make-smoothies-with-a-kick 2022-03-21T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/03/21/lumen-bioscience-announces-publication-in-nature-biotechnology-detailing-spirulina-based-platform-for-ultra-large-scale-production-of-therapeutic-proteins 2022-03-21T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/03/21/development-of-spirulina-for-the-manufacture-and-oral-delivery-of-protein-therapeutics 2022-03-21T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/03/19/delivery-systems-for-biologics 2022-03-19T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/02/01/intranasal-passive-vaccines-thinking-beyond-the-jab-1 2022-02-01T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/01/31/special-report-reinventing-biologic-drugs 2022-01-31T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/01/24/reengineering-biologics-manufacturing-and-access 2022-01-24T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/01/17/from-superfood-to-medicine-maker-spirulina-is-a-new-cellular-factory 2022-01-17T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/01/14/using-antibody-synergy-to-engineer-a-high-potency-biologic-cocktail-against-c-difficile 2022-01-14T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2022/01/10/stopping-a-global-killer-lumen-bioscience-takes-aim-at-deadly-diarrheal-disease-in-resource-limited-settings 2022-01-10T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/12/24/antibody-synergy 2021-12-24T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/12/22/lumen-reversed-logo-science-pipeline-news-about-careers-contact-news-lumen-bioscience-releases-data-on-potent-orally-delivered-biologic-drug-cocktail-for-preventing-c-difficile-infection 2021-12-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/11/29/democratizing-biologics-with-lumen-biosciences-brian-finrow-j-d-and-craig-behnke-ph-d 2021-11-29T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/11/20/development-of-an-intranasal-oral-spirulina-based-pf-csp-malaria-vaccine 2021-11-20T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/11/03/lumen-bioscience-partners-with-leading-animal-health-company-to-develop-oral-biologic-drugs-and-reduce-antibiotic-use-on-farms 2021-11-03T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/10/29/design-of-functionalised-circular-tandem-repeat-proteins-with-longer-repeat-topologies-and-enhanced-subunit-contact-surfaces-1 2021-10-29T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/10/12/covid-drugs-come-in-3-flavors-it-s-time-for-more-diversity 2021-10-12T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/10/08/lumen-lands-another-dod-contract-to-treat-covid-related-gi-issues 2021-10-08T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/10/06/covid-therapies-must-look-beyond-the-lungs-1 2021-10-06T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/10/05/lumen-bioscience-awarded-federal-funding-to-advance-covid-19-antibody-cocktail-through-phase-2-clinical-evaluation 2021-10-05T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/09/22/unlocking-biologic-drug-production 2021-09-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/31/lumen-bioscience-launches-phase-1-trial-of-oral-biologic-drug-for-preventing-c-difficile-infection-recurrence 2021-08-31T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/27/magic-bullets-for-all-democratising-biologics-by-rethinking-antibody-development-manufacturing-and-delivery-1 2021-08-27T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/11/plant-based-biologics-all-the-rage-as-lumen-partners-with-google 2021-08-11T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/11/seattle-startup-lumen-bioscience-is-working-with-google-to-make-drugs-using-algae-1 2021-08-11T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/11/machine-learning-meets-molecular-farming 2021-08-11T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/10/lumen-bioscience-teams-with-google-to-apply-machine-learning-to-biologics-manufacturing 2021-08-10T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/10/all-about-biologics-with-lumen-bioscience-ceo-brian-finrow 2021-08-10T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/08/08/machine-learning-optimization-of-photosynthetic-microbe-cultivation-and-recombinant-protein-production 2021-08-08T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/07/23/lumen-plots-site-at-nearby-seattle-bakery-as-it-ramps-up-production-of-algae-based-biologics 2021-07-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/07/22/seattles-lumen-will-move-into-new-headquarters-in-former-long-lived-bakery-amid-trial-expansion 2021-07-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/07/15/lumen-reversed-logo-science-pipeline-news-about-careers-contact-news-seattle-startup-lumen-biosciences-to-build-algae-manufacturing-plant-in-former-bakery 2021-07-15T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/07/12/lumen-bioscience-expands-biologics-manufacturing-capacity-with-lease-of-historic-seattle-bakery 2021-07-12T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/06/16/lumen-bioscience-and-novo-nordisk-enter-into-research-collaboration-to-explore-novel-strategies-to-deliver-oral-biologics-for-cardiometabolic-disease 2021-06-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/06/16/lumen-and-novo-nordisk-link-up-on-oral-biologics-for-cardiometabolic-disease 2021-06-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/06/16/the-ideal-platform-to-fight-a-silent-pandemic 2021-06-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/06/16/novo-nordisk-partners-with-seattle-biopharm-to-research-develop-obesity-therapies 2021-06-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/04/21/lumen-bioscience-announces-appointment-of-marcos-milla-ph-d-to-board-of-directors-expansion-of-leadership-team 2021-04-21T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/03/30/developing-a-biologic-to-prevent-gastrointestinal-diseases 2021-03-30T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/03/18/ultra-rapid-low-cost-neutralizing-antibody-therapeutic-for-covid-19 2021-03-18T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/02/16/beyond-the-lung-treating-the-gi-symptoms-of-covid-19 2021-02-16T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/02/12/lumen-bioscience-receives-carb-x-award-to-develop-preventative-for-deadly-diarrheal-diseases-and-details-broad-potential-of-spirulina-platform-2 2021-02-12T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/02/12/carb-x-awards-5-3m-to-lumen-for-diarrheal-disease-research-development 2021-02-12T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/02/12/high-impact-drugs-at-dirt-cheap-cost 2021-02-12T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/02/12/lumen-to-earn-up-to-14-5-million-from-carb-x-for-antidiarrheal 2021-02-12T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/01/27/lumen-bioscience-receives-carb-x-award-to-develop-preventative-for-deadly-diarrheal-diseases-and-details-broad-potential-of-spirulina-platform 2021-01-27T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2021/01/27/expression-and-manufacturing-of-protein-therapeutics-in-spirulina 2021-01-27T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/11/23/with-a-4m-federal-grant-lumen-jumps-into-the-covid-19-treatment-race 2020-11-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/11/23/lumen-bioscience-reels-in-16m-series-b-to-democratize-biologics 2020-11-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/11/23/lumen-bags-u-s-grant-for-gi-focused-covid-19-antibody-cocktail 2020-11-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/11/11/q-and-a-with-lumen-using-spirulina-to-manufacture-covid-19-antibodies 2020-11-11T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/10/07/lumen-bioscience-announces-appointment-of-dr-mark-litton-to-board-of-directors 2020-10-07T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/09/22/lumen-bioscience-awarded-federal-grant-to-rapidly-develop-antibody-based-covid-19-therapeutic 2020-09-22T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/09/01/lumen-bioscience-raises-16m-series-b-financing-to-accelerate-clinical-development-of-accessible-biologic-drugs 2020-09-01T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/08/26/camelid-nanobodies-poised-to-revolutionize-antibody-therapeutics 2020-08-26T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/08/04/lysins-unlimited-phages-secret-weapon 2020-08-04T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/08/03/seattle-biotech-startup-lumen-bioscience-raises-11-2m-to-develop-drugs-using-algae 2020-08-03T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/08/03/spirulina-platform-lumen-large-as-firm-bags-series-a-therapies-and-more-ahead 2020-08-03T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/08/03/fred-hutch-and-adaptive-biotechnologies-vets-raise-13m-for-biotech-startup 2020-08-03T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/07/23/dr-craig-behnke-joins-lumen-bioscience-as-svp-production-and-development 2020-07-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/07/23/lumen-wins-triple-funding-boost-to-advance-development-of-low-cost-therapeutics-for-newborns-and-infants-in-developing-countries 2020-07-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/07/23/lumen-bioscience-announces-issuance-of-us-patent-for-genetic-modification-of-spirulina 2020-07-23T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/07/08/nih-awards-grant-to-lumen-bioscience-for-cost-effective-oral-malaria-vaccine 2020-07-08T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/07/08/lumen-bioscience-hires-executive-to-scale-blue-green-algae-technology 2020-07-08T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/04/01/lumen-wins-grant-to-develop-ultra-low-cost-therapeutics-for-treating-infant-diseases-in-developing-countries 2020-04-01T00:00:00.000Z monthly 0.7 https://lumen.bio/news/2020/03/21/you-cant-get-there-from-here-birth-of-a-biotech-platform 2020-03-21T00:00:00.000Z monthly 0.7